-
1
-
-
0032840918
-
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
-
doi:10.1002/(SICI)1096-9896(199909)189:1. PubMed: 10451482
-
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer A et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19. doi:10.1002/(SICI)1096-9896(199909)189:1. PubMed: 10451482.
-
(1999)
J Pathol
, vol.189
, pp. 12-19
-
-
Walboomers, J.M.1
Jacobs, M.V.2
Manos, M.M.3
Bosch, F.X.4
Kummer, A.5
-
2
-
-
78049528352
-
Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional survey
-
doi:10.1016/S1470-2045(10)70230-8. PubMed: 20952254
-
de Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey. Lancet Oncol 11: 1048-1056. doi:10.1016/S1470-2045(10)70230-8. PubMed: 20952254.
-
(2010)
Lancet Oncol
, vol.11
, pp. 1048-1056
-
-
De Sanjose, S.1
Quint, W.G.V.2
Alemany, L.3
Geraets, D.T.4
Klaustermeier, J.E.5
-
3
-
-
0037310596
-
Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students
-
DOI 10.1093/aje/kwf180
-
Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218-226. doi:10.1093/aje/kwf180. PubMed: 12543621. (Pubitemid 36152435)
-
(2003)
American Journal of Epidemiology
, vol.157
, Issue.3
, pp. 218-226
-
-
Winer, R.L.1
Lee, S.-K.2
Hughes, J.P.3
Adam, D.E.4
Kiviat, N.B.5
Koutsky, L.A.6
-
4
-
-
0028047650
-
Persistence of type-specific human papillomavirus infection among cytologically normal women
-
Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE et al. (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169: 235-240. doi: 10.1093/infdis/169.2.235. PubMed: 8106758. (Pubitemid 24045578)
-
(1994)
Journal of Infectious Diseases
, vol.169
, Issue.2
, pp. 235-240
-
-
Hildesheim, A.1
Schiffman, M.H.2
Gravitt, P.E.3
Glass, A.G.4
Greer, C.E.5
Zhang, T.6
Scott, D.R.7
Rush, B.B.8
Lawler, P.9
Sherman, M.E.10
Kurman, R.J.11
Manos, M.M.12
-
5
-
-
46749137498
-
Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis
-
DOI 10.1093/aje/kwn036
-
Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D et al. (2008) Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 168: 123-137. doi:10.1093/aje/kwn036. PubMed: 18483125. (Pubitemid 351951589)
-
(2008)
American Journal of Epidemiology
, vol.168
, Issue.2
, pp. 123-137
-
-
Koshiol, J.1
Lindsay, L.2
Pimenta, J.M.3
Poole, C.4
Jenkins, D.5
Smith, J.S.6
-
6
-
-
33644518674
-
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies
-
International Collaboration of Epidemiological Studies of Cervical Cancer
-
International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, et al. (2006) Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118: 1481-1495
-
(2006)
Int J Cancer
, vol.118
, pp. 1481-1495
-
-
Appleby, P.1
Beral, V.2
De Berrington González, A.3
-
7
-
-
33846622321
-
Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
-
International Collaboration of Epidemiological Studies of Cervical Cancer PubMed: 17131323
-
International Collaboration of Epidemiological Studies of Cervical Cancer (2007) Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120: 885-891 PubMed: 17131323
-
(2007)
Int J Cancer
, vol.120
, pp. 885-891
-
-
-
8
-
-
66649131375
-
Cervical carcinoma and sexual behavior: Collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies
-
International Collaboration of Epidemiological Studies of Cervical Cancer
-
International Collaboration of Epidemiological Studies of Cervical Cancer. (2009) Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 18: 1060-1069
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1060-1069
-
-
-
9
-
-
69249085668
-
Risk of human papillomavirus-associated cancers among persons with AIDS
-
PubMed: 19648510
-
Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA (2009) Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 101: 1120-1130. PubMed: 19648510.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1120-1130
-
-
Chaturvedi, A.K.1
Madeleine, M.M.2
Biggar, R.J.3
Engels, E.A.4
-
10
-
-
0036467961
-
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
-
DOI 10.1086/338569
-
Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C et al. (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324-331. doi:10.1086/338569. PubMed: 11807714. (Pubitemid 34107245)
-
(2002)
Journal of Infectious Diseases
, vol.185
, Issue.3
, pp. 324-331
-
-
Smith, J.S.1
Munoz, N.2
Herrero, R.3
Eluf-Neto, J.4
Ngelangel, C.5
Franceschi, S.6
Bosch, F.X.7
Walboomers, J.M.M.8
Peeling, R.W.9
-
11
-
-
0037032499
-
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
-
Smith JS, Herrero R, Bosetti C, Muñoz N, Bosch FX et al. (2002b) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94: 1604-1613. doi:10.1093/jnci/94. 21.1604. PubMed: 12419786. (Pubitemid 35378725)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.21
, pp. 1604-1613
-
-
Smith, J.S.1
Herrero, R.2
Bosetti, C.3
Munoz, N.4
Bosch, F.X.5
Eluf-Neto, J.6
Castellsague, X.7
Meijer, C.J.L.M.8
Van Den, B.A.J.C.9
Franceschi, S.10
Ashley, R.11
-
12
-
-
60749099876
-
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2
-
PubMed: 19104355
-
Castle PE, Schiffman M, Wheeler CM, Solomon D (2009) Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 113: 18-25. PubMed: 19104355.
-
(2009)
Obstet Gynecol
, vol.113
, pp. 18-25
-
-
Castle, P.E.1
Schiffman, M.2
Wheeler, C.M.3
Solomon, D.4
-
13
-
-
34250850161
-
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial
-
doi:10.1016/S0140-6736(07)60946-5. PubMed: 17602732
-
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J et al. (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369: 2161-2170. doi:10.1016/S0140-6736(07)60946-5. PubMed: 17602732.
-
(2007)
Lancet
, vol.369
, pp. 2161-2170
-
-
Paavonen, J.1
Jenkins, D.2
Bosch, F.X.3
Naud, P.4
Salmerón, J.5
-
14
-
-
67651049056
-
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women
-
doi:10.1016/S0140-6736(09)61248-4. PubMed: 19586656
-
Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow S-N et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314. doi:10.1016/S0140-6736(09)61248-4. PubMed: 19586656.
-
(2009)
Lancet
, vol.374
, pp. 301-314
-
-
Paavonen, J.1
Naud, P.2
Salmerón, J.3
Wheeler, C.M.4
Chow, S.-N.5
-
15
-
-
33748784911
-
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR
-
DOI 10.1128/JCM.00539-06
-
van Doorn L-J, Molijn A, Kleter B, Quint W, Colau B (2006) Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 44: 3292-3298. doi:10.1128/JCM.00539-06. PubMed: 16954263. (Pubitemid 44413767)
-
(2006)
Journal of Clinical Microbiology
, vol.44
, Issue.9
, pp. 3292-3298
-
-
Van Doorn, L.-J.1
Molijn, A.2
Kleter, B.3
Quint, W.4
Colau, B.5
-
16
-
-
84868554266
-
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women enrolled in the multinational PATRICIA trial
-
doi:10.1016/j.ygyno.2012.08.033. PubMed: 22940493
-
Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN et al. (2012) Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women enrolled in the multinational PATRICIA trial. Gynecol Oncol 127: 440-450. doi:10.1016/j.ygyno.2012.08.033. PubMed: 22940493.
-
(2012)
Gynecol Oncol
, vol.127
, pp. 440-450
-
-
Roset Bahmanyar, E.1
Paavonen, J.2
Naud, P.3
Salmerón, J.4
Chow, S.N.5
-
17
-
-
84892372742
-
The robust inference for the Cox proportional hazards model
-
doi: 10.1080/01621459.1989.10478874
-
Lin DY, Wei LJ (1989) The robust inference for the Cox proportional hazards model. J American Statistical Assoc 84: 1074-1078. doi: 10.1080/01621459.1989.10478874.
-
(1989)
J American Statistical Assoc
, vol.84
, pp. 1074-1078
-
-
Lin, D.Y.1
Wei, L.J.2
-
18
-
-
0022673130
-
Longitudinal data analysis for discrete and continuous outcomes
-
doi:10.2307/2531248. PubMed: 3719049
-
Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130. doi:10.2307/2531248. PubMed: 3719049.
-
(1986)
Biometrics
, vol.42
, pp. 121-130
-
-
Zeger, S.L.1
Liang, K.Y.2
-
19
-
-
63649116323
-
Human papillomavirus genotype distributions: Implications for vaccination and cancer screening in the United States
-
doi:10.1093/jnci/djn510. PubMed: 19318628
-
Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WGV et al. (2009) Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101: 475-487. doi:10.1093/jnci/djn510. PubMed: 19318628.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 475-487
-
-
Wheeler, C.M.1
Hunt, W.C.2
Joste, N.E.3
Key, C.R.4
Quint, W.G.V.5
-
20
-
-
21144433509
-
The carcinogenicity of human papillomavirus types reflects viral evolution
-
DOI 10.1016/j.virol.2005.04.002, PII S0042682205002096
-
Schiffman M, Herrero R, DeSalle R, Hildesheim A, Wacholder S et al. (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337: 76-84. doi:10.1016/j.virol.2005.04.002. PubMed: 15914222. (Pubitemid 40725441)
-
(2005)
Virology
, vol.337
, Issue.1
, pp. 76-84
-
-
Schiffman, M.1
Herrero, R.2
Desalle, R.3
Hildesheim, A.4
Wacholder, S.5
Rodriguez, A.C.6
Bratti, M.C.7
Sherman, M.E.8
Morales, J.9
Guillen, D.10
Alfaro, M.11
Hutchinson, M.12
Wright, T.C.13
Solomon, D.14
Chen, Z.15
Schussler, J.16
Castle, P.E.17
Burk, R.D.18
-
21
-
-
25444450857
-
Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse
-
doi:10.1002/ijc.21210. PubMed: 15900579
-
Bulkmans NW, Bleeker MCG, Berkhof J, Voorhorst FJ, Snijders PJF et al. (2005) Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 117: 177-191. doi:10.1002/ijc.21210. PubMed: 15900579.
-
(2005)
Int J Cancer
, vol.117
, pp. 177-191
-
-
Bulkmans, N.W.1
Bleeker, M.C.G.2
Berkhof, J.3
Voorhorst, F.J.4
Snijders, P.J.F.5
-
22
-
-
79951656791
-
Incident cervical HPV infections in young women: Transition probabilities for CIN and infection clearance
-
FUTURE I. Investigators doi: 10.1158/1055-9965.EPI-10-0791. PubMed: 21300618
-
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM et al.; FUTURE I. Investigators (2011) Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev 20: 287-296 doi: 10.1158/1055-9965.EPI-10-0791. PubMed: 21300618.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 287-296
-
-
Insinga, R.P.1
Perez, G.2
Wheeler, C.M.3
Koutsky, L.A.4
Garland, S.M.5
-
23
-
-
84871378209
-
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
-
doi:10.1002/ijc.27713. Epub ahead of print PubMed: 22752992
-
Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM et al. (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer, 132: 854-67. doi:10.1002/ijc.27713. Epub ahead of print PubMed: 22752992.
-
(2013)
Int J Cancer
, vol.132
, pp. 854-867
-
-
Tjalma, W.A.1
Fiander, A.2
Reich, O.3
Powell, N.4
Nowakowski, A.M.5
-
24
-
-
75949102203
-
Estimating progression rates for human papillomavirus infection from epidemiological data
-
doi: 10.1177/0272989X09336140. PubMed: 19525483
-
Jit M, Gay N, Soldan K, Hong Choi Y, Edmunds WJ (2010) Estimating progression rates for human papillomavirus infection from epidemiological data. Med Decis Making 30: 84-98. doi: 10.1177/0272989X09336140. PubMed: 19525483.
-
(2010)
Med Decis Making
, vol.30
, pp. 84-98
-
-
Jit, M.1
Gay, N.2
Soldan, K.3
Hong Choi, Y.4
Edmunds, W.J.5
-
25
-
-
0035162141
-
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types
-
DOI 10.1086/317638
-
Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S et al. (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183: 8-15. doi:10.1086/317638. PubMed: 11087198. (Pubitemid 32043036)
-
(2001)
Journal of Infectious Diseases
, vol.183
, Issue.1
, pp. 8-15
-
-
Liaw, K.-L.1
Hildesheim, A.2
Burk, R.D.3
Gravitt, P.4
Wacholder, S.5
Manos, M.M.6
Scott, D.R.7
Sherman, M.E.8
Kurman, R.J.9
Glass, A.G.10
Anderson, S.M.11
Schiffman, M.12
-
26
-
-
0035892786
-
Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection
-
DOI 10.1086/324579
-
Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE et al. (2001) Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 184: 1508-1517. doi:10.1086/324579. PubMed: 11740725. (Pubitemid 33139735)
-
(2001)
Journal of Infectious Diseases
, vol.184
, Issue.12
, pp. 1508-1517
-
-
Rousseau, M.-C.1
Pereira, J.S.2
Prado, J.C.M.3
Villa, L.L.4
Rohan, T.E.5
Franco, E.L.6
-
27
-
-
25444452470
-
Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines
-
DOI 10.1086/444391
-
Mendez F, Munoz N, Posso H, Molano M, Moreno V et al. (2005) Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 192: 1158-1165. doi:10.1086/444391. PubMed: 16136457. (Pubitemid 41368414)
-
(2005)
Journal of Infectious Diseases
, vol.192
, Issue.7
, pp. 1158-1165
-
-
Mendez, F.1
Munoz, N.2
Posso, H.3
Molano, M.4
Moreno, V.5
Van Den, B.A.J.C.6
Ronderos, M.7
Meijer, C.8
Munoz, A.9
-
28
-
-
0038518244
-
Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated
-
Weissenborn SJ, Funke AM, Hellmich M, Mallmann P, Fuchs PG et al. (2003) Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 41: 2763-2767. doi:10.1128/JCM.41.6.2763-2767.2003. PubMed: 12791926. (Pubitemid 36712513)
-
(2003)
Journal of Clinical Microbiology
, vol.41
, Issue.6
, pp. 2763-2767
-
-
Weissenborn, S.J.1
Funke, A.M.2
Hellmich, M.3
Mallmann, P.4
Fuchs, P.G.5
Pfister, H.J.6
Wieland, U.7
-
29
-
-
76149140074
-
Concurrent infection with multiple human papillomavirus types: Pooled analysis of the IARC HPV Prevalence Surveys
-
doi:10.1158/1055-9965.EPI-09-0983. PubMed: 20142247
-
Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ et al. (2010) Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 19: 503-510. doi:10.1158/1055-9965.EPI-09-0983. PubMed: 20142247.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 503-510
-
-
Vaccarella, S.1
Franceschi, S.2
Snijders, P.J.3
Herrero, R.4
Meijer, C.J.5
-
30
-
-
84862771858
-
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer Screening (NTCC) Working Group
-
doi:10.1016/j.ejca.2011.10.010. PubMed: 22088483
-
Carozzi F, Ronco G, Gillio-Tos A, De Marco L, Del Mistro D et al. (2012) Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer Screening (NTCC) Working Group. Eur J Cancer 48: 1633-1637. doi:10.1016/j.ejca.2011.10.010. PubMed: 22088483.
-
(2012)
Eur J Cancer
, vol.48
, pp. 1633-1637
-
-
Carozzi, F.1
Ronco, G.2
Gillio-Tos, A.3
De Marco, L.4
Del Mistro, D.5
-
31
-
-
79960122395
-
Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica
-
Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez Ac, et al. (2011) Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 204: 385-390
-
(2011)
J Infect Dis
, vol.204
, pp. 385-390
-
-
Vaccarella, S.1
Franceschi, S.2
Herrero, R.3
Schiffman, M.4
Rodriguez, Ac.5
-
32
-
-
34247567222
-
High-risk HPV type-specific clearance rates in cervical screening
-
DOI 10.1038/sj.bjc.6603653, PII 6603653
-
Bulkmans NW, Berkhof J, Bulk S, Bleeker MC, van Kemenade FJ et al. (2007) High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 96: 1419-1424. PubMed: 17342094. (Pubitemid 46685773)
-
(2007)
British Journal of Cancer
, vol.96
, Issue.9
, pp. 1419-1424
-
-
Bulkmans, N.W.J.1
Berkhof, J.2
Bulk, S.3
Bleeker, M.C.G.4
Van Kemenade, F.J.5
Rozendaal, L.6
Snijders, P.J.F.7
Meijer, C.J.L.M.8
-
33
-
-
84855300842
-
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
-
doi:10.1016/S1470-2045(11)70286-8. PubMed: 22075171
-
Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM et al. (2012) Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 13: 89-99. doi:10.1016/S1470-2045(11)70286-8. PubMed: 22075171.
-
(2012)
Lancet Oncol
, vol.13
, pp. 89-99
-
-
Lehtinen, M.1
Paavonen, J.2
Wheeler, C.M.3
Jaisamrarn, U.4
Garland, S.M.5
-
34
-
-
84860564294
-
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
-
doi:10.1309/AJCPTGD94EVRSJCG. PubMed: 22431528
-
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137: 516-542. doi:10.1309/AJCPTGD94EVRSJCG. PubMed: 22431528.
-
(2012)
Am J Clin Pathol
, vol.137
, pp. 516-542
-
-
Saslow, D.1
Solomon, D.2
Lawson, H.W.3
Killackey, M.4
Kulasingam, S.L.5
|